1 Composition and formation
C5 convertase is a transient enzyme complex of the complement system that forms on target surfaces during complement activation. Its main function is to cleave complement component C5, a step that bridges upstream recognition events with downstream inflammatory and lytic responses. Because the complex is assembled from earlier complement fragments, its composition differs according to the pathway that produced it.
1.1 Role in the complement cascade
The complement cascade is organized as a sequence of protein activation steps. Earlier convertases first amplify the response by generating large amounts of C3 cleavage products, which decorate microbial or altered host surfaces. When sufficient C3b accumulates, the pathway shifts to a C5-cleaving stage. This transition is important because it commits the reaction toward terminal complement activation and membrane attack complex formation.
1.2 Classical and lectin pathway C5 convertase
In the classical and lectin pathways, the C5 convertase is derived from the C3 convertase C4b2a after an additional C3b molecule associates with the complex. The resulting enzyme is typically written as C4b2a3b. It retains the recognition features of the earlier convertase while gaining the ability to process C5 efficiently.
1.2.1 Formation from C4b2a3b
Formation begins when C4b2a is deposited on a surface and cleaves more C3, producing C3b. One C3b molecule then binds to the convertase, creating a higher-order complex with improved affinity for C5. This assembly is surface-bound and short-lived, which helps confine complement activation to the location where the initiating event occurred.
1.3 Alternative pathway C5 convertase
In the alternative pathway, the corresponding C5 convertase is formed from the C3 convertase C3bBb after binding of an additional C3b molecule. The mature complex is commonly written as C3bBb3b. Like the classical and lectin pathway enzyme, it is membrane-associated and functions mainly on activator surfaces.
1.3.1 Formation from C3bBb3b
The alternative pathway includes a self-amplifying loop in which C3b generation promotes further convertase formation. When another C3b associates with C3bBb, the resulting complex becomes able to cleave C5. This arrangement allows rapid expansion of complement activity on surfaces that favor C3b deposition.
1.4 Surface stabilization and amplification
Convertase formation is strongly influenced by the local surface environment. Microbial carbohydrates, immune complexes, and other activating structures can favor stable attachment of C3b-containing complexes. At the same time, the alternative pathway amplification loop increases the density of C3b, making C5 convertase assembly more likely. This positive feedback helps concentrate the complement response where it is needed.
2 Enzymatic function
C5 convertase performs a single, highly consequential proteolytic reaction. Although the complex is not abundant or durable, its catalytic action determines whether the complement response remains mainly amplifying or proceeds to terminal effector mechanisms. The products of C5 cleavage have distinct and complementary roles.
2.1 Cleavage of C5
The convertase binds C5 and cuts it into two fragments at a specific site. This cleavage is tightly regulated by convertase structure, surface attachment, and the presence of additional C3b molecules. Compared with earlier convertases, the C5-cleaving form has a different substrate preference and is adapted to process the larger C5 molecule.
2.2 Generation of C5a and C5b
C5 cleavage produces C5a, a soluble inflammatory mediator, and C5b, a fragment that initiates terminal complement assembly. These two products diverge rapidly in function. C5a acts locally to influence cells of the immune system, while C5b remains associated with the pathway that builds the membrane attack complex.
2.2.1 Biological activity of C5a
C5a is one of the most potent complement-derived signaling molecules. It promotes leukocyte recruitment, increases vascular permeability, and enhances activation of neutrophils and other immune cells. Because of these effects, even small amounts of C5a can amplify inflammation and shape the cellular response to infection or tissue injury.
2.2.2 Initiation of membrane attack complex assembly
C5b exposes binding sites that allow sequential association with complement proteins C6, C7, C8, and multiple C9 molecules. This stepwise process forms the membrane attack complex, a pore-like structure that can disrupt susceptible membranes. C5 convertase therefore serves as the gateway to direct complement-mediated lysis.
3 Regulation
Complement activation must remain focused and limited, since uncontrolled convertase activity can damage host tissue. Regulation is achieved by plasma and membrane-associated proteins that destabilize the complex, block substrate access, or promote irreversible inactivation of deposited complement fragments. These controls are essential for preserving self-tolerance at the surface level.
3.1 Complement control proteins
Several regulatory proteins modulate C5 convertase function, including decay-accelerating factor, complement receptor 1, membrane cofactor protein, factor H, and factor I. Some act mainly on the convertase itself, while others assist in dismantling or inactivating C3b-containing structures. Their distribution on host cells helps distinguish self from activating surfaces.
3.2 Decay acceleration
Decay acceleration refers to the dissociation of convertase components before substantial substrate cleavage can occur. By breaking apart the enzymatic complex, regulators sharply reduce catalytic activity. This mechanism is particularly important for limiting complement on host membranes, where even transient assembly could otherwise trigger damage.
3.3 Cofactor-dependent inactivation
Cofactor-dependent inactivation involves the proteolytic cleavage of C3b or related fragments by factor I in the presence of helper proteins such as factor H or membrane cofactor protein. Once these fragments are inactivated, they can no longer support convertase assembly efficiently. This process decreases the chance that C5 convertase will form or persist on protected host surfaces.
4 Biological significance
The biological importance of C5 convertase lies in its position at the transition between amplification and effector execution. By producing C5a and C5b, it integrates recognition of danger with both inflammatory signaling and direct antimicrobial action. Its activity is therefore central to many outcomes traditionally associated with complement activation.
4.1 Innate immune defense
C5 convertase contributes to innate immune defense by helping the body respond quickly to pathogens. It acts after complement has recognized a target, ensuring that effector functions are deployed in a localized manner. The result is a coordinated response that supports phagocyte recruitment, opsonization, and direct pathogen injury.
4.2 Inflammation and chemotaxis
Through the generation of C5a, the enzyme promotes chemotaxis and activation of immune cells. Neutrophils are especially responsive, moving toward sites where complement is active. This activity can improve microbial clearance, but if excessive it may also intensify local tissue inflammation.
4.3 Membrane attack complex formation
By producing C5b, C5 convertase initiates membrane attack complex assembly. This pathway is particularly effective against some bacteria and other susceptible targets. Even when lysis is incomplete, the terminal complement pathway can alter membrane integrity and contribute to immune clearance.
5 Clinical relevance
Because C5 convertase sits near the end of the complement cascade, abnormalities in its formation, regulation, or downstream products can have significant clinical consequences. Interest in this enzyme has grown as complement biology has become a therapeutic target in several diseases. The clinical focus often concerns either excessive activation or insufficient terminal complement function.
5.1 Complement deficiencies
Inherited deficiencies affecting complement components that support C5 convertase formation can reduce terminal pathway activity. Such defects may impair efficient opsonization, inflammation, or membrane attack complex assembly. Depending on the specific protein involved, affected individuals may be more vulnerable to certain infections.
5.2 Complement-mediated diseases
Overactive complement activation can contribute to tissue injury in immune-mediated disorders. In these settings, excessive C5 convertase activity may increase C5a generation and promote inflammatory damage. Disease processes involving complement dysregulation often reflect a failure of regulatory proteins to restrain convertase activity on host cells.
5.3 Therapeutic inhibition of C5 activation
Several therapies aim to block C5 cleavage or downstream effects of terminal complement activation. By preventing C5 convertase from generating C5a and C5b, these approaches can reduce inflammation and membrane attack complex formation. Such inhibition is valuable in conditions where terminal complement activity is harmful rather than protective.
6 Research methods
C5 convertase has been studied using biochemical, structural, and functional approaches. Because the enzyme complex is membrane-associated and relatively unstable, experimental design often requires careful control of surface composition, protein concentration, and reaction timing. Reconstitution systems have been especially useful for defining its assembly.
6.1 Assays for convertase activity
Convertase activity is commonly measured by monitoring cleavage of C5 or surrogate substrates. These assays may use purified proteins, cell surfaces, or artificial membranes. Product detection can involve electrophoresis, immunoblotting, or functional readouts tied to terminal complement activation.
6.2 Structural studies
Structural analysis has helped clarify how C3b-containing complexes engage C5. Techniques such as X-ray crystallography and cryo-electron microscopy have provided insight into subunit arrangement and substrate recognition. These studies also support models explaining why the addition of a second C3b molecule shifts the complex from C3 to C5 specificity.
6.3 Reconstitution experiments
Reconstitution experiments rebuild the convertase from purified components to test assembly requirements under controlled conditions. By varying C3b, factor B, factor D, and regulatory proteins, researchers can identify steps that promote or inhibit C5 convertase formation. Such experiments are valuable for distinguishing direct catalytic effects from broader pathway amplification.